Spero Therapeutics, Inc. (SPRO) Earnings Per Share (EPS)
Spero Therapeutics, Inc. (SPRO) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | -$3.52 |
| 2021-12-31 | -$2.91 |
| 2022-12-31 | -$1.23 |
| 2023-12-31 | $0.43 |
| 2024-12-31 | -$1.27 |
| 2025-12-31 | $0.15 |
How SPRO compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| VCEL | Vericel Corporation | $0.32 |
| NEOG | Neogen Corporation | -$0.04 |
| TRVI | Trevi Therapeutics Inc. | -$0.32 |
| ACRS | Aclaris Therapeutics Inc. | -$0.53 |
| CRVS | Corvus Pharmaceuticals Inc. | -$0.53 |
These are five companies in the same sector as SPRO with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Spero Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("SPRO")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SPRO | $1.23 | -0.41% | 0.22M |
| 3 | ||||
| 4 | ||||
| 5 |